RA

RA Capital Management

VC
Boston, MAWebsite
How to approach: warm intro preferred
Stage

Seed, Pre-Seed

Check Size

$1.0M – $5.0M

AUM

$12.6B

Portfolio

11+ companies

Team

11 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

RA Capital specializes in identifying and supporting transformative life sciences ventures, with a deep focus on biotech and innovative pharmaceuticals.

How RA Capital Management invests

RA Capital Management is a vc firm based in Boston, MA. The firm invests at the Seed, Pre-Seed stages, with a focus on Healthcare, Other.

RA Capital Management typically writes checks of $1.0M–$5.0M per investment, backed by approximately $13B in assets under management.

RA Capital Management has backed 11 companies in our records, including Spero Therapeutics, Aimmune Therapeutics, Lusaris Therapeutics.

Meet the Team

PK

Peter Kolchinsky

Managing Partner

MH

Matthew Hammond

Partner

MA

Manas Adhikari

Finance Director

SV

Shawn Valliere

Head of Family Office

RS

Rebecca Silberman

Investment Director

SS

Shan Shan Wang

Associate Director

BJ

Brendan Joyce

Tax Director

KM

Kate Moreau

Director

KM

Kathryn Meng

Investment Director

BS

Brent Sanders

Chief Information Officer

LS

Laura Stoppel

Partner

public and private investments
Board Director for Artiva Biotherapeutics, Nimbus Therapeutics, and Acumen Pharmaceuticals

Laura Stoppel is a Partner on the Investment Team at RA Capital Management. Laura works on both public and private investments and serves as a Board Director for Artiva Biotherapeutics, Nimbus Therapeutics, and Acumen Pharmaceuticals. Previously, Laura covered hematologic malignancies, cell therapies, retinal diseases, and orphan neurodevelopmental disorders. Her graduate research investigated synaptic translation in syndromic autism. Laura holds a BA in Biology and Psychology from Harvard University and a PhD in Neuroscience from MIT.

Industry Focus

Invests In

Healthcare
Other

Portfolio Companies (11)

Other

SP

Spero Therapeutics

Biotech
AI

Aimmune Therapeutics

Pharmaceuticals
LU

Lusaris Therapeutics

EL

Eliem Therapeutics

AE

Aerovate Therapeutics

IM

Imbria Pharmaceuticals

AT

Athenen Therapeutics

RA

RA Capital Planetary Health Fund, L.P. (CIK 0001979194)

SEC Form D filing mentioning RA Capital Management

RA

RA Capital Healthcare Fund LP (CIK 0001315082)

SEC Form D filing mentioning RA Capital Management

RA

RA Capital Planetary Health International Fund, L.P. (CIK 0001979199)

SEC Form D filing mentioning RA Capital Management

How to pitch RA Capital Management
  • Raising at Seed, Pre-Seed? You're squarely in their sweet spot.
  • Lead with your fit in Healthcare, Other — the sectors they actively back.
  • Size your ask to their typical $1.0M – $5.0M check.
  • warm intro preferred
  • Address your outreach to a specific partner, such as Peter Kolchinsky, Managing Partner.
  • A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if RA Capital Management is a match for your startup

Upload your pitch deck to see how well you match with RA Capital Management and 10,000+ other investors.

Is this your profile? Request a correction or removal